News

The most accessed research studies in the Journal of the American College of Cardiology (JACC) in 2014 spanned many topics, including a blood test to rule out heart attack, an advisory...

Philips has signed an agreement with Image Stream Medical (ISM) that allows Philips to further expand its hybrid suite and interventional lab solutions with integrated video and live...

Bayer unveiled version 2.5 of its Radimetrics Enterprise Platform at the 2014 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting. The enhanced version has new...

Vital Images Inc., AAA, fenestrated stents, endovascular stent planning, Vitrea

Vital Images Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Fenestrated Stent Planning workflow as part of its existing Endovascular Stent Planning (EVSP)...

Flat Panel Displays, RSNA 2014, Hybrid OR, Medvik Series

Ampronix reintroduced its Medvix line of near-patient surgical displays. 

C-arms, mobile R/F systems, Angiography systems, RSNA 2014

Ampronix announced the availability of its new LCD retrofit kit for the OEC 9800 mobile C-Arm.

Advanced Vascular Dynamics, RadAR vascular compression device

Advanced Vascular Dynamics (AVD) announced U.S. Food and Drug Administration (FDA) clearance and CE mark for the RadAR vascular compression devices for post-procedure hemostasis of tibiopedal...

AliveCor Heart Monitor, third generation, ECG, atrial fibrillation, AF

AliveCor Inc. announced the launch of its third-generation AliveCor Heart Monitor. Now users have the ability to identify and manage heart conditions with a U.S. Food and Drug Administration...

According to the Dell Global Technology Adoption Index, 96 percent of mid-size healthcare organizations surveyed are using or considering using cloud computing.

Clinical trial/study, stents, venous therapies

Veniti Inc. announced that it has enrolled the first United States patients in the Virtus trial of the Veniti VICI Venous Stent System.

Ultrasound systems, RSNA 2014, Aplio 300 and 500 Platinum series

With the introduction of the Aplio 300 and 500 Platinum Series from Toshiba America Medical Systems Inc., clinicians can now meet goals of the Centers for Medicare & Medicaid Services’ (CMS)...

Cardionovum GmbH announced that it has initiated a 150-patient clinical study of its novel paclitaxel-releasing, high-pressure shunt balloon dilatation catheter, Aperto.

Covidien, Solitaire, stent thrombectomy, trial, Netherlands

In a landmark study evaluating the addition of stent thrombectomy clot removal to pharmaceutical treatment for patients suffering an acute ischemic stroke (AIS), stent thrombectomy provided a...

Atrial fibrillation, heart valve repair, software, mobile devices, ACC app

The American College of Cardiology’s recently released Guideline Clinical App has expanded with the addition of tools and guideline content for two conditions, valvular heart disease and...

EP lab, Clinical Trial/Study, Pacemakers, MRI Systems, Biotronik

Biotronik announced that Phase B of its ProMRI study has completed patient enrollment and concluded all planned scans.

ReFlow Medical Inc., SpeX shapeable support catheter, FDA

ReFlow Medical Inc. announced U.S. Food and Drug Administration (FDA) clearance for commercialization of their SpeX shapeable support catheter in the United States for use in the peripheral...

diaDexus, PLAC Test for Lp-PLA2 Activity,

The U.S. Food and Drug Administration (FDA) cleared a new screening test that predicts a patient’s risk of future coronary heart disease (CHD) events, such as heart attacks.

Having been active in the age of transformation in which manufacturing, retail, finance, high-tech and oil and gas all experienced in the late 1980s and into the 1990s, I realized that healthcare...

EP Lab, Atrial Fibrilation, RhythmView 3-D Mapping System, MIP Award

Topera, Inc. announced that its RhythmView 3-D Mapping System received the Most Innovative New Product (MIP) Award at the 2014 CONNECT MIP Awards.

Radiation dose management, RSNA 2014, CT systems, Comprehensive dose strategy

Sapheneia has partnered with Scannerside to provide a comprehensive dose strategy (CDS) to the medical imaging industry.